INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 21 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | – | 2,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMS Capital Management | 20,146 | $7,000 | 0.00% |
| VANGUARD GROUP INC | 292,603 | $101,000 | 0.00% |
| UBS Group AG | 25,171 | $9,000 | 0.00% |
| IFP Advisors, Inc | 1 | $1,000 | 0.00% |
| Sugarloaf Wealth Management, LLC | 1 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 112 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 212 | $0 | 0.00% |
| NORTHERN TRUST CORP | 70,536 | $24,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |